Literature DB >> 16594900

Importance of carbohydrate in the interaction of Tamm-Horsfall protein with complement 1q and inhibition of classical complement activation.

Diana C J Rhodes1.   

Abstract

Tamm-Horsfall protein (THP) binds strongly to complement 1q (C1q), a key component of the classical complement pathway. The goals of this study were to determine whether THP altered the activation of the classical complement pathway and whether the carbohydrate portion of THP was involved in this glycoprotein's binding to C1q and alteration of complement activation. The ability of THP to prevent complement activation in diluted serum or plasma incubated at 37 degrees C was assessed using both a haemolytic assay with antibody-sensitized sheep RBC and a C4d ELISA. Both these methods showed that THP inhibited activation of the classical complement pathway in a dose-dependent manner. Glycosidases were used to remove most of the carbohydrate from THP. This partially deglycosylated THP bound human IgG with a higher affinity (KD1 = 1.4 nmol/L; KD2 = 0.31 micromol/L) than did intact THP (KD1 = 33.4 nmol/L; KD2 = 31.0 micromol/L). An ELISA showed that removal of carbohydrate from THP reduced, but did not eliminate, the ability of this protein to inhibit binding of C1q to intact THP. Haemolysis assays using antibody-sensitized sheep RBC showed that removal of THP carbohydrate eliminated the ability of THP to protect against complement activation. In conclusion, THP inhibited the activation of the classical complement pathway that occurred in diluted serum or plasma. The carbohydrate moieties of THP appeared to be important in this inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16594900     DOI: 10.1111/j.1440-1711.2006.01434.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  8 in total

1.  Tamm-Horsfall protein regulates circulating and renal cytokines by affecting glomerular filtration rate and acting as a urinary cytokine trap.

Authors:  Yan Liu; Tarek M El-Achkar; Xue-Ru Wu
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Glycodendrimers and Modified ELISAs: Tools to Elucidate Multivalent Interactions of Galectins 1 and 3.

Authors:  Mark Wolfenden; Jonathan Cousin; Pratima Nangia-Makker; Avraham Raz; Mary Cloninger
Journal:  Molecules       Date:  2015-04-20       Impact factor: 4.411

3.  Human Tamm-Horsfall protein, a renal specific protein, serves as a cofactor in complement 3b degradation.

Authors:  Diana C J Rhodes
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

4.  Uromodulin deficiency alters tubular injury and interstitial inflammation but not fibrosis in experimental obstructive nephropathy.

Authors:  Olena Maydan; Paul G McDade; Yan Liu; Xue-Ru Wu; Douglas G Matsell; Allison A Eddy
Journal:  Physiol Rep       Date:  2018-03

Review 5.  Tamm-Horsfall Protein is a Potent Immunomodulatory Molecule and a Disease Biomarker in the Urinary System.

Authors:  Tsai-Hung Wu; Ko-Jen Li; Chia-Li Yu; Chang-Youh Tsai
Journal:  Molecules       Date:  2018-01-22       Impact factor: 4.411

6.  The importance of sialic acid, pH and ion concentration on the interaction of uromodulin and complement factor H.

Authors:  Lufeng Bai; Qiuyu Xie; Min Xia; Kunjing Gong; Na Wang; Yuqing Chen; Minghui Zhao
Journal:  J Cell Mol Med       Date:  2021-03-31       Impact factor: 5.310

7.  Importance of glycosylation in the interaction of Tamm-Horsfall protein with collectin-11 and acute kidney injury.

Authors:  Kunjing Gong; Min Xia; Yaqin Wang; Lufeng Bai; Wantao Ying; Fengxue Zhu; Yuqing Chen
Journal:  J Cell Mol Med       Date:  2020-02-11       Impact factor: 5.310

8.  Serum uromodulin is inversely associated with biomarkers of subclinical inflammation in the population-based KORA F4 study.

Authors:  Cornelia Then; Christian Herder; Holger Then; Barbara Thorand; Cornelia Huth; Margit Heier; Christa Meisinger; Annette Peters; Wolfgang Koenig; Wolfgang Rathmann; Michael Roden; Michael Stumvoll; Haifa Maalmi; Thomas Meitinger; Andreas Lechner; Jürgen Scherberich; Jochen Seissler
Journal:  Clin Kidney J       Date:  2020-09-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.